Delivering transformative action in paediatric pain: a Lancet Child & Adolescent Health Commission

TY - JOUR

T1 - Delivering transformative action in paediatric pain

T2 - a Lancet Child & Adolescent Health Commission

AU - Chambers, Christine T.

N1 - Funding Information: We thank The MayDay Fund (New York City, NY, USA) and Versus Arthritis (London, UK) for their financial support for this manuscript, which included funding meetings to discuss the Commission. The funders had no other role in the development of the Commission. CE and RFH report grants from National Institute for Health Research UK. EF is a Versus Arthritis Career Development Fellow. CTC is funded by the Canadian Institutes of Health Research and other granting agencies. CS is funded by a K23 Award from the US National Institutes of Health (GM123372), a grant from the Boston Center for Endometriosis/Marriott Foundation Investigator Award, and a grant from the Department of Defense (W81XWH1910560). We also thank Rachel Deere (University of Bath, Bath, UK) for her help in preparing the manuscript for submission, as well as Andrew Moore (Newton Ferrers, Devon, UK) and Neil O'Connell (Brunell University London, London, UK) for their comments on an earlier version of the manuscript. Funding Information: RFH reports grants from Great Ormond Street Hospital Children's Charity, SPARKS Charity, Louis Dundas Foundation Medical Charity; and personal fees (for research consultancy) from Grünenthal and Regeneron UK, and personal fees (for regulatory consultancy) from Wockhardt UK, outside the submitted work. KB is Assistant Scientific Director of Solutions for Kids in Pain and declares no competing interests. CTC is Scientific Director of the Canadian Institutes of Health Research Institute of Human Development, Child and Youth Health, and Scientific Director of Solutions for Kids in Pain, and declares no competing interests. SMW reports grants from Sintetica, personal fees from Advisory Board for Regeneron Pharmaceuticals, and speaking fees from Takeda Pharmaceuticals for her presentation on pain research, outside the submitted work. All other authors declare no competing interests.

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85095436715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095436715&partnerID=8YFLogxK

U2 - 10.1016/S2352-4642(20)30277-7

DO - 10.1016/S2352-4642(20)30277-7

M3 - Review article

C2 - 33064998

AN - SCOPUS:85095436715

SN - 2352-4642

VL - 5

SP - 47

EP - 87

JO - The Lancet Child and Adolescent Health

JF - The Lancet Child and Adolescent Health

IS - 1

ER -